Načítá se...
A Three-Tier Chemotherapy Response Score For Ovarian/Fallopian Tube/Peritoneal High Grade Serous Carcinoma, Is It Clinically Relevant?
The chemotherapy response score (CRS) is used to score histopathologic response to neoadjuvant chemotherapy (NACT) of patients with extrauterine high grade serous carcinoma. This study was undertaken to determine if the CRS in the omentum, adnexa or when combined correlates with 1) progression free...
Uloženo v:
| Vydáno v: | Am J Surg Pathol |
|---|---|
| Hlavní autoři: | , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6954274/ https://ncbi.nlm.nih.gov/pubmed/31651523 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/PAS.0000000000001391 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|